Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas - Wikidata - awgldk - TriplyDB

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

http://www.wikidata.org/entity/Q35403440

about

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.A complete compilation of matrix metalloproteinase expression in human malignant gliomas.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3

P2860

Q36871155-58C9AE64-57ED-40E5-93A9-FF701861F899 Q38009800-DA052164-6375-4460-9B03-006DF6DD1C4F Q38205134-C54F8C1C-0711-4126-81FC-964060B3DAF2 Q38870841-B897D401-3B2E-4E6C-BBD2-AB137A879D2D Q58554018-F452A4C5-FF7E-4CDD-9819-23B2E37A8B19

P2860

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

http://www.wikidata.org/entity/Q35403440

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@ast

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@en

type

label

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@ast

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@en

prefLabel

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@ast

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@en

P1433

Q35403440-B4557206-1D79-4D9D-A777-4A2377ABC186

P1476

Q35403440-8CE733C8-61EF-4F13-88CA-9D23EE3ABC9F

P2093

Q35403440-0312850C-4487-4417-9E70-64E901312DB7

Q35403440-4AEA6AEE-E115-4372-890F-0973A3F078DD

Q35403440-6FEBE5E1-AD4C-47DC-B653-326FC03EA8BE

Q35403440-807C9172-20FE-44F3-9A51-3374735FEFAF

Q35403440-AAE19BF8-B8E0-47FC-9AC3-45A4D9714318

Q35403440-AAE2D6D2-ECCE-4FCA-A608-CE1665B86D13

Q35403440-FFDFC71F-5B6E-428D-A25E-8A78D092AB9B

P2860

Q35403440-0539452C-DDE5-481F-AF6E-CC1D50627E8E

Q35403440-0EB392FF-12C5-414D-AEAE-85CAF0E42071

Q35403440-24247D25-2635-4BD6-A183-E5168A4F66FA

Q35403440-2585FB77-A1B3-4A33-B69E-70C9AA507213

Q35403440-27874588-009D-4C1B-AABE-ACA9E15508E1

Q35403440-27B43B4E-1659-4D54-AB65-CC2B6EA6A82A

Q35403440-5867B18D-7CAE-4EA1-82BA-C0CFD841FFD7

Q35403440-5A81560B-7658-4C89-A17A-A766A9B6F156

Q35403440-601074A3-E483-45CA-8923-FF9B88488B48

Q35403440-6547C794-B8BA-46A6-82AF-A58EC97FFA46

P2888

Q35403440-5397C983-20A7-47A6-804A-7296CE0BC744

P304

Q35403440-3194D4FA-F819-40E2-9019-B9041F2F500F

P31

Q35403440-E1E79330-3733-4BF9-9FFE-F450DA94C7A5

P356

Q35403440-3B63D6C6-437D-4FF1-B2A4-7A46EDE8C873

P433

Q35403440-B3EBD610-526D-425C-8AE6-DC94638EEBCA

P478

Q35403440-0B75A21D-2309-4A23-821E-551233F5BA12

P50

Q35403440-C7787338-A1AD-4D4A-AD86-B64AC4148199

Q35403440-CABBE4CF-808C-4A1B-B7FC-DCA5CC759CE5

P577

Q35403440-931EB9B2-9D6B-4749-9BE9-B41CD4824A03

P5875

Q35403440-4F270B6F-8A8F-47B8-BC28-534D982227C6

P698

Q35403440-AFB81D6C-18A3-4878-8893-FD79EF7B4800

P932

Q35403440-28A99E65-313F-4A28-B907-6CFAD094DAC2

P356

S11060-011-0602-9

P1433

Journal of Neuro-Oncology

P1476

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

@en

P2093

Jane B Alavi

http://www.w3.org/2001/XMLSchema#string

Joy D Fisher

http://www.w3.org/2001/XMLSchema#string

Michelle A Rudek

http://www.w3.org/2001/XMLSchema#string

Pamela New

http://www.w3.org/2001/XMLSchema#string

Stuart A Grossman

http://www.w3.org/2001/XMLSchema#string

Surasak Phuphanich

http://www.w3.org/2001/XMLSchema#string

Tom Mikkelsen

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.

Development of matrix metalloproteinase inhibitors in cancer therapy.

A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties.

Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells

A mechanistic approach to antiepileptic drug interactions.

Drug-induced lupus associated with COL-3: report of 3 cases.

Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer.

Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.

Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study.

P2888

s11060-011-0602-9

P304

375-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-011-0602-9

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Steven T Piantadosi

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51102928

http://www.w3.org/2001/XMLSchema#string

P698

21547395

http://www.w3.org/2001/XMLSchema#string

P932

3197967

http://www.w3.org/2001/XMLSchema#string